Our News on Newswise

Immunotherapy Combination Improves Outcomes in Advanced Kidney Cancer

An immunotherapy agent combined with a tyrosine kinase inhibitor drug significantly improved progression-free survival and reduced the risk of death compared to a single agent treatment in advanced kidney cancer patients, according to first results...
19-Sep-2020 12:05 AM EDT Add to Favorites

Daily coffee consumption associated with improved survival in patients with metastatic colorectal cancer

In a large group of patients with metastatic colorectal cancer, consumption of a few cups of coffee a day was associated with longer survival and a lower risk of the cancer worsening, researchers at Dana-Farber Cancer Institute and other...
16-Sep-2020 1:05 PM EDT Add to Favorites

Dana-Farber to offer first CAR T-cell therapy for mantle cell lymphoma following FDA approval

Today’s Food and Drug Administration (FDA) approval of the first CAR T-cell therapy for mantle cell lymphoma (MCL) represents a key advance for patients with relapsed or treatment-resistant forms of the disease, say Dana-Farber Cancer Institute...
24-Jul-2020 3:10 PM EDT Add to Favorites

Prostate cancer metastasis linked to revival of dormant molecular program

When prostate cancer progresses to a more-dangerous metastatic state, it does so by resurrecting dormant molecular mechanisms that had guided the fetal development of the prostate gland but had been subsequently switched off, say scientists from...
19-Jul-2020 7:05 AM EDT Add to Favorites

Newswise: EdwardBenz_DFCI.jpg

Dana-Farber President & CEO Emeritus receives ASH Award for Leadership in Promoting Diversity

Edward J. Benz, Jr., MD, President and CEO Emeritus of the Dana-Farber Cancer Institute and the Richard and Susan Smith Distinguished Professor at Harvard Medical School, has received the 2020 ASH Award for Leadership in Promoting Diversity.
23-Jun-2020 10:00 AM EDT Add to Favorites

Biomarker test highly accurate in detecting early kidney cancer

A novel liquid biopsy method can detect kidney cancers with high accuracy, including small, localized tumors which are often curable but for which no early detection method exists, say scientists from Dana-Farber Cancer Institute. The report in...
22-Jun-2020 9:00 AM EDT Add to Favorites

Newswise: EricZhou_DFCI.jpg

Online program significantly improves insomnia in adolescent and young adult cancer survivors, study finds

In a study published today by Pediatric Blood and Cancer, researchers at Dana-Farber Cancer Institute show that an online program developed specifically for AYA cancer survivors can significantly alleviate insomnia and improve overall quality of...
22-Jun-2020 6:35 AM EDT Add to Favorites

Drug with new approach on impeding DNA repair shows promise in first clinical trial

Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer
15-Jun-2020 9:20 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

Newswise: AnnPartridge.jpg

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

Newswise: PF_SOG_7837.jpg

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

Newswise: Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Newswise: Andrea_Patenaude.jpg

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

Newswise: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

Healthy Holiday Helpings: Experts Offer Tips to Fight Cancer with Your Fork This Holiday Season

The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT

See All Experts

Our YouTube Videos

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Contacts

Ellen Berlin
Media Relations Director

ellen_berlin@dfci.harvard.edu

617-632-5357

Robert Levy
Science Writer

robert_levy@dfci.harvard.edu

617-632-4090

Molly McHale
Associate Director for Communications

molly_mchale@dfci.harvard.edu

617-632-5675

Richard Saltus
Senior Science Writer

richard_saltus@dfci.harvard.edu

617-632-5643

Donna Walthall
Marketing Director

donna_walthall@dfci.harvard.edu

617-632-5856

Marlena Baldacci
National Media Relations Manager

marlena_Baldacci@dfci.harvard.edu

857-215-1204

Peter Cohenno
Senior Media Relations Specialist

Peter_Cohenno@dfci.harvard.edu

Claire Monaghan
Senior Media Relations Specialist
hematology

Claire_Monaghan@dfci.harvard.edu

617-632-5653

John Noble
Senior Media Relations Specialist
Health Care

johnw_noble@dfci.harvard.edu

617-632-5784

Quincey Spagnoletti
Media Relations Specialist

quinceym_spagnoletti@dfci.harvard.edu

315-720-2715

Victoria Warren
Media Relations Manager

Victoria_Warren@dfci.harvard.edu

617-582-9323

Twitter

close
0.74041